NYSEARCA:BBP Virtus LifeSci Biotech Products ETF (BBP) Price, Holdings, & News $105.92 -2.79 (-2.57%) As of 08/28/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort Interest About Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BBP alerts:Sign Up Key Stats Today's Range$105.62▼$108.4150-Day Range$91.63▼$109.9052-Week Range$67.06▼$110.05Volume7,048 shsAverage Volume8,367 shsMarket Capitalization$105.92 millionAssets Under Management$116.34 millionDividend YieldN/ANet Expense Ratio0.34%Aggregate RatingModerate Buy ETF Overview The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus. Read More Virtus LifeSci Biotech Products ETF ExpensesTypeBBPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.34%0.55%0.57%0.51%0.53%Other Expenses0.00%0.52%0.53%0.60%0.54%Total Expense0.34%0.76%0.75%0.75%0.73%Fee Waiver0.00%-0.85%-0.67%-0.77%-0.68%Net Expense0.34%0.58%0.63%0.57%0.60% Receive BBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Products ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBP ETF News HeadlinesBBP: The Biotech ETF That Filters For FDA-Approved DrugsAugust 20, 2026 | seekingalpha.comBiotech ETF (BBC) touches a new 52-week highJune 30, 2026 | msn.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.August 30 at 1:00 AM | Porter & Company (Ad)Virtus Biotech Products ETFMay 30, 2026 | wsj.comVirtus LifeSci Biotech Clinical Trials ETF declares annual distribution of $0.6554December 23, 2025 | msn.com5 small-cap biotech ETFs to watchDecember 11, 2025 | msn.comSee More Headlines BBP ETF - Frequently Asked Questions How have BBP shares performed this year? Virtus LifeSci Biotech Products ETF's stock was trading at $79.91 at the beginning of 2026. Since then, BBP stock has increased by 32.5% and is now trading at $105.92. How do I buy shares of Virtus LifeSci Biotech Products ETF? Shares of BBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Virtus LifeSci Biotech Products ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Products ETF investors own include Inovio Pharmaceuticals (INO), Micron Technology (MU), Sanofi (SNY), Gilead Sciences (GILD), Simon Property Group (SPG), Intel (INTC) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Fund Details IssuerVirtus Fund NameVirtus LifeSci Biotech Products ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BBP Inception Date12/16/2014 Fund ManagerMatthew B. Brown, Seth Kadushin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci Biotechnology Products Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings71 Fund Statistics Assets Under Management$116.34 million Average Daily Volume$9.78 thousand Discount/Premium0.15% Administrator, Advisor and Custodian AdministratorVirtus ETF Solutions, LLC AdvisorVirtus ETF Advisers, LLC CustodianThe Bank of New York Mellon Corporation DistributorETF Distributors LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest32,428 shs Miscellaneous Outstanding Shares1,000,000Beta0.56 Creation Unit50,000 Creation Fee$500.00 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report Top 10 BBP HoldingsCrinetics Pharmaceuticals (NASDAQ:CRNX)Holding Weight: 3.13%Omeros (NASDAQ:OMER)Holding Weight: 2.51%Iovance Biotherapeutics (NASDAQ:IOVA)Holding Weight: 2.18%Verastem (NASDAQ:VSTM)Holding Weight: 2.05%Zai Lab (NASDAQ:ZLAB)Holding Weight: 1.94%Kiniksa Pharmaceuticals International (NASDAQ:KNSA)Holding Weight: 1.89%Halozyme Therapeutics (NASDAQ:HALO)Holding Weight: 1.81%Protagonist Therapeutics (NASDAQ:PTGX)Holding Weight: 1.80%Precigen (NASDAQ:PGEN)Holding Weight: 1.75%ACADIA Pharmaceuticals (NASDAQ:ACAD)Holding Weight: 1.71%Full Holdings DetailsBBP Sector ExposureBBP Industry Exposure This page (NYSEARCA:BBP) was last updated on 8/30/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredSPDR Gold just lost $14 billion.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredLook at this $5 stock’s addressA small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, ...Freedom Financial | SponsoredIran War: What Happened at 1:11 P.M. Outside D.C.?A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...Banyan Hill Publishing | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
